Currently, an ongoing clinical trial since 2020 (NCT04412187) employs TSPO-PET imaging technology to dynamically monitor the phenotypic switching of microglia and systematically assess the evolution of neuroinflammation post-stroke. The gene discussed is TSPO; the disease is stroke disorder.